"The
Report Malignant Pleural Mesothelioma Global Clinical Trials Review,
H2, 2016 provides information on pricing, market analysis, shares,
forecast, and company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's
clinical trial report, Malignant
Pleural Mesothelioma Global
Clinical Trials Review, H2, 2016" provides an overview of
Malignant Pleural Mesothelioma clinical trials scenario. This report
provides top line data relating to the clinical trials on Malignant
Pleural Mesothelioma. Report includes an overview of trial numbers
and their average enrollment in top countries conducted across the
globe. The report offers coverage of disease clinical trials by
region, country (G7 & E7), phase, trial status, end points status
and sponsor type. Report also provides prominent drugs for
in-progress trials (based on number of ongoing trials). GlobalData
Clinical Trial Reports are generated using GlobalDatas proprietary
database - Pharma eTrack Clinical trials database. Clinical trials
are collated from 80+ different clinical trial registries,
conferences, journals, news etc across the globe. Clinical trials
database undergoes periodic update by dynamic process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Get
Sample Copy Of This Report At :
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons
to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing
to Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Countries Contributing to
Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing
to Clinical Trials in Central and South America 13
Clinical Trials by G7
Countries: Proportion of Malignant Pleural Mesothelioma to Oncology
Clinical Trials 14
Clinical Trials by Phase in G7
Countries 15
Clinical Trials in G7 Countries
by Trial Status 16
Clinical Trials by E7
Countries: Proportion of Malignant Pleural Mesothelioma to Oncology
Clinical Trials 17
Clinical Trials by Phase in E7
Countries 18
Clinical Trials in E7 Countries
by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status
22
Clinical Trials by End Point
Status 23
Subjects Recruited Over a
Period of Time 24
Clinical Trials by Sponsor Type
25
Prominent Sponsors 26
Top Companies Participating in
Malignant Pleural Mesothelioma Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on
Malignant Pleural Mesothelioma 30
Sep 06, 2016: Mesothelioma
Treatment Center at Baylor St. Lukes launches clinical trial for
cancer patients 30
Sep 06, 2016: Mesothelioma
Treatment Center at Baylor St. Lukes launches clinical trial of
cancer combination therapy 30
Jul 05, 2016: Targovax presents
encouraging preclinical data on ONCOS-102 31
Clinical Trial Profile
Snapshots 32
Appendix 180
Abbreviations 180
Definitions 180
Research Methodology 181
Secondary Research 181
About GlobalData 182
Contact Us 182
Disclaimer 182
Source 183
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment